Transcription of STADA Key Figures
{{id}} {{{paragraph}}}
02 STADA Key FiguresSTADA KEY FIGURESKey Figures for the Group in million 20172016 %Group sales2 ,313 .92 , 13 9. 2+8% Generics1, , +6% Branded .5+11%Operating profit192 . +8% 5. 2+19 % Branded Products9 +22%EBITDA363. 8361 .5+1% Generics292 . +14% Branded Products2 0 4 . +10 %Net sales adjusted for currency and portfolio effects 2, , 1)+6% Generics1, , 1)+4% Branded 1)+9%Operating profit, adjusted 2) 3)32 +9% Generics24 2+16% Branded Products156 . 2152 . 8+2%EBITDA, adjusted 2) 3) +9% +14% Branded Products2 0 7. +3%Net income, adjusted 2) 3)19 5. 617 +10%Cash flow from operating activities262 . 1%Investments1 13 . and amortization (net of write-ups) (average number based on full-time employees)4)10,83210,8390%Employees (as of the reporting date based on full-time employees)10,17610,923-7%Key share figures20172016 %Market capitalization (year-end) in million5, , 0 6 6 .3+79 %Year-end closing price (XETRA ) in 9.
06 Letter to Shareholders from the STADA CEO LETTER TO SHAREHOLDERS FROM THE STADA CEO Dr. Claudio Albrecht, Chairman of the Executive Board of STADA Arzneimittel AG Dear Shareholders, Ladies and Gentlemen,
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}